Need Help? Call 1­-866-­796-­7386
« back to stock screener

  KALV stock: Kalvista Pharmaceuticals Inc

Current Rating
Sell

Previous Rating

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$16.08
Market Cap
205M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
6.76
P/S
21.96
Dividend %
-
P/CF
9.3
P/FCF
22.9
Op. Cash Flow
10.6K
FCF
0.7
Op. Margin
-224.00%
Net Margin
-188.30%
ROE
-55.60%
ROI
-67.80%
ROA
-32.70%
EPS Growth
76.50%
Current Ratio
2.6
Debt/Equity
0.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Endo International PLC (ENDP) $15.94 - - 3.74B Strong Buy
Vaxart Inc (VXRT) $2.42 - - 21.9M Strong Buy
Biostem Technologies Inc (BSEM) $3.99 - - 32M Strong Buy
Procyon Corp (PCYN) $0.23 - - 2M Strong Buy
Cumberland Pharmaceuticals, In (CPIX) $5.62 - - 96.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More